4.8 Article

Overexpression of mRNA-binding protein CRD-BP in malignant melanomas

Journal

ONCOGENE
Volume 27, Issue 37, Pages 5069-5074

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2008.141

Keywords

CRD-BP; beta-TrCP; mRNA stability; melanoma; Wnt/beta-catenin signaling; NF-kappa B

Funding

  1. NCI [CA121851]

Ask authors/readers for more resources

Wnt/beta-catenin signaling pathway plays an important role in embryogenesis, stem cell maintenance, tumorigenesis and aging. Here, we show that RNA-binding protein, coding region determinant-binding protein (CRD-BP) (a transcriptional target of Wnt signaling pathway), is highly expressed in primary human malignant melanomas and melanoma cell lines with activated Wnt/beta-catenin signaling pathway. Upregulation of CRD-BP is associated with an elevated level of beta-TrCP1 ubiquitin ligase receptor and activation of nuclear transcriptional factors-kappa B (NF-kappa B) signaling. Knockdown of CRD-BP inhibits NF-kappa B activity, induces apoptosis, and suppresses proliferation and tumorigenic properties of melanoma cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available